Glenmark receives ANDA approval for Aspirin and generic version of Aggrenox® Capsules

India |  News | 0 Comment | 27 May, 2019

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg,...Read more

Varian to acquire Cancer Treatment Services International for $283M

India |  News | 0 Comment | 21 May, 2019

Taking an important step to accelerate innovation of new multidisciplinary solutions to address the growing global cancer burden, Varian Medical Systems has announced that it has entered&nb...Read more

Dyadic, Serum Institute of India collaborate for antibodies and vaccines

India |  News | 0 Comment | 14 May, 2019

Dyadic International, a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower production...Read more

DWC sets up first dedicated wound care centre in India

India |  News | 0 Comment | 08 May, 2019

Dalvkot Wound Care (DWC), a one-of-its-kind wound care centre, has launched its first dedicated wound care centre at Vydehi Campus, Whitefield, Bengaluru, India. DWC, a brain child of Dr Ma...Read more

Glenmark appoints Dr. Yasir Rawjee as CEO of Glenmark Life Sciences

India |  News | 0 Comment | 07 May, 2019

Glenmark Pharmaceuticals Ltd has announced that it has appointed Dr. Yasir Rawjee as the Chief Executive Officer of Glenmark Life Sciences Ltd, its subsidiary for the API(Active Pharmaceuti...Read more

Glenmark Therapeutics announces Co-Promotion Agreement with Otonomy

India |  News | 0 Comment | 03 May, 2019

Glenmark Therapeutics has announced a co-promotion agreement with Otonomy, a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. Glenmark The...Read more

SIFI, Zydus to launch innovative intraocular lenses in India

India |  News | 0 Comment | 01 May, 2019

SIFI, the Italian leader in the development of therapeutic solutions to treat ophthalmic disorders and global pharmaceutical major, Zydus Cadila, have tied up to market innovative IOLs (Int...Read more

Alchem launches micronized digoxin platform

India |  News | 0 Comment | 25 Apr, 2019

Alchem International Private Limited ("Alchem"), a privately held pharmaceutical company focused on the production of pharmaceutical active ingredients derived from plants (API), announced ...Read more

mfine raises $17.2 M to create largest virtual healthcare delivery network

India |  News | 0 Comment | 24 Apr, 2019

mfine, a health-tech AI startup from India, has raised $17.2 million in Series B funding. The investment was led by SBI Investment, a Japan-based venture ...Read more

Alembic’s Ophthalmic Solution gets USFDA approval

India |  News | 0 Comment | 23 Apr, 2019

Alembic Pharmaceuticals Limited recently announced that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) ...Read more

M3 acquires majority share in DailyRounds

India |  News | 0 Comment | 22 Apr, 2019

M3, Inc. of Japan announced acquisition of a majority stake of India based Neuroglia Health Private Limited (NHPL), a leading provider of mobile and web-based applications for Doctors and M...Read more

India to be one of the world’s ‘fastest growing bio’ hubs in 2019: CPhI data

India |  News | 0 Comment | 18 Apr, 2019

New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India spe...Read more

Roche launches Emicizumab in India

India |  News | 0 Comment | 21 Apr, 2019

Roche has declared  that Emicizumab (Hemlibra®) has been approved in India for Hemophilia A with factor VIII inhibitors. It is indicated as a prophylactic(preventive) treatment to ...Read more

Zydus Cadila announces phase III trial of Desidustat

India |  News | 0 Comment | 17 Apr, 2019

Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the Phase III trials of Desidustat, an Investigational New Drug targeted at treating anemia in non-dialysis depe...Read more

TA Associates announces partnership with Indira IVF

India |  News | 0 Comment | 16 Apr, 2019

TA Associates, global growth private equity firm has announced that it has completed a significant minority investment in Indira IVF, a leading India-based infertility treatment provider. F...Read more

Six Indian Institutes establish joint Doctoral Training Group on Bio Big Data Science

India |  News | 0 Comment | 11 Apr, 2019

Six leading Indian Institutes of Higher Education are collaborating to establish up the first Joint Indian-German Research Training Group (RTG) on Bio Big Data Science to promote the use of...Read more

nULTA partners with PhonePe and TISS to help patients deal with mental health issues

India |  News | 0 Comment | 09 Apr, 2019

Roy de Souza, a serial entrepreneur focused on curing cancer has funded nULTA,  a leading online consultation platform that connects patients to specialist doctors. The app has pa...Read more

Sun Pharma launches INFUGEM in the U.S.

India |  News | 0 Comment | 08 Apr, 2019

India-based Sun Pharmaceutical Industries Ltd. has announced that  INFUGEM  (gemcitabine in sodium chloride injection), for intravenous use, is now commercially availabl...Read more